Related Experiment Video
Updated: Aug 29, 2026

Pulsed Wave Doppler Assessment of Diastolic Dysfunction in the ZSF-1 Rat Model of Pulmonary Hypertension Due to Left Heart Disease
Published on: May 22, 2026
[Diastolic heart failure]
Y M Smulders1, C D Stehouwer, J G Bronzwaer
1Afd. Inwendige Geneeskunde, VU Medisch Centrum, De Boelelaan 1117, 1081 HV Amsterdam. y.smulders@vumc.nl
Insights
Diastolic heart failure, common in the elderly, shares a similar prognosis to systolic heart failure. Optimal medical treatment remains unclear, though some drugs show potential while others may be contraindicated.
Area of Science:
- Cardiology
- Geriatric Medicine
Context:
- Diastolic heart failure (DHF) disproportionately affects the elderly, with nearly half of heart failure patients over 70 having DHF.
- Hypertension and obesity are frequently observed comorbidities in DHF patients.
Purpose:
- To summarize the current understanding of diastolic heart failure, including its prevalence, associated conditions, prognosis, diagnostic methods, and potential therapeutic strategies.
- To highlight the diagnostic utility of echocardiography in differentiating DHF from systolic heart failure.
- To address the existing gap in evidence regarding optimal pharmacological interventions for DHF.
Summary:
- DHF is a significant condition in older adults, often linked to hypertension and obesity.
- Prognosis for DHF is comparable to systolic heart failure, and echocardiography is key for diagnosis, identifying diastolic dysfunction in patients with normal ejection fraction.
- Optimal medical treatment for DHF lacks robust data, but angiotensin-converting enzyme (ACE) inhibitors, beta-blockers, and non-dihydropyridine calcium antagonists are potential options, whereas digoxin may be contraindicated.
Impact:
- Informs clinical practice regarding the diagnosis and management of diastolic heart failure, particularly in elderly populations.
- Guides future research by identifying the need for evidence-based treatment strategies for DHF.
- Enhances understanding of DHF's impact on patient outcomes and the limitations of current therapeutic approaches.
Abstract:
Diastolic heart failure is predominantly a disease of the elderly: at the age of 70 years, almost half of all patients with heart failure have diastolic heart failure. Hypertension and obesity are common underlying disorders in patients with diastolic heart failure. Patients with diastolic heart failure have an equal, or only slightly better, prognosis in terms of mortality compared to patients with systolic heart failure. Echocardiography can distinguish diastolic heart failure from systolic heart failure. Patients with heart failure and a normal ejection fraction almost certainly have a diastolic dysfunction. There is a lack of reliable data about the optimal medicinal treatment strategy for patients with diastolic heart failure. Angiotensin-converting enzyme (ACE) inhibitors, beta-blockers, and (non-dihydropyridine) calcium antagonists have therapeutic potential. Digoxin may be contraindicated.
Related Concept Videos
Heart Failure II: Pathophysiology
Heart Failure III: Clinical Manifestations
Heart Failure I: Introduction
Pathophysiology of Heart Failure
Heart Failure IV: Classification and Diagnostic Evaluation
Mitral Regurgitation I: Introduction
